• Welcome to Specialised Therapeutics
  • SE Asia (HQ)

    +65 3158 9940

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

October 2019 - ST acquires rights to market YONDELIS® (trabectedin) in Australia, NZ and South East Asia

ST signs further licensing agreement with Spanish partner PharmaMar